Menu
Log in
Log in

News

Management of Clinical T2N0 Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment?

30 Aug 2022 5:43 PM | Anonymous

Rolfy A. Perez Holguin, Elizabeth J. Olecki, Kelly A. Stahl, William G. Wong, Charles C. Vining, Matthew E. B. Dixon & June S. Peng

Read Abstract: Management of Clinical T2N0 Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment?

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software